bauplan | $7,500,000 | (Apr 17, 2025)
Finch(US) | Undisclosed Amount | (Apr 17, 2025)
Glycomine Inc. | $115,000,000 | (Apr 17, 2025)
Certified by Founder
Lodge
Myricx Bio
start up
United Kingdom
- London
- 09/07/2024
- Series A
- $115,246,800
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.
- Industry Biotechnology Research
- Website https://myricxbio.com/
- LinkedIn https://www.linkedin.com/company/myricx-pharma-ltd/
Atomic(US1) | $3,000,000 | (Apr 17, 2025)
Skin Analytics | $19,833,225 | (Apr 17, 2025)
PeopleForce | $5,400,000 | (Apr 17, 2025)
telli (YC F24) | $3,600,000 | (Apr 17, 2025)
Blue Onion | $10,000,000 | (Apr 17, 2025)
Inephany | $2,200,000 | (Apr 17, 2025)
Luma Financial Technologies | $63,000,000 | (Apr 17, 2025)
Scout AI | $15,000,000 | (Apr 17, 2025)
Tundr | $8,187,552 | (Apr 17, 2025)